Non-valvular Atrial Fibrillation
📧 Sign up to get email alerts when something new happens for Non-valvular Atrial Fibrillation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2016-08-17Clinical Trial Update: Early Post-marketing Study of Eliquis (Apixaban)
The trial update notes that an early post-marketing study of Eliquis (apixaban) for non-valvular atrial fibrillation has been withdrawn.